Reference Library
What is the Reference Library?
Keeping current with the retina literature is, for most, an ongoing, futile effort. New journals are constantly being introduced, and existing journals keep getting thicker and thicker. Researching a topic on PubMed doesn’t allow you to spot key references or quickly digest what’s new globally on a topic of interest. And remembering what you’ve read a few weeks later (or even after you’ve turned the page to the next article) is a struggle.
To address these concerns, we pull key clinical references from 24 major ophthalmic and retinal journals each month (click here for the journal list). Although we can’t provide the journal article PDF due to copyright issues, we provide a single-line citation with a brief summary of the article’s main points. Our goal is to capture all major clinically relevant references.
Please contact us if we’re missing any key references or if any reference is mis-summarized or cited.
Want to Automatically Receive Our Monthly Journal Article Summaries?
That’s easy! Just subscribe to the Retina World Congress’s monthly email blast here.
How is the Reference Library integrated into the Image Library?
At the top of most Image Library folders is a ___References Word document containing the annotated bibliography for that topic. Every month, we file key articles into the appropriate Retina Rocks folder(s) and update this file. Key articles are located at the top of the list. This allows for a rapid snapshot and review of the literature while also looking through our multimedia images. Some seemingly unrelated references are included in each folder to aid in differential diagnosis or to learn about similar findings in other disorders.
Key Retina Journal Articles of the Month
Here is the current month's snapshot of key retina journal articles
Monthly Archives
Intraretinal Fibrosis in Macular Telangiectasia Type-2: Clinical and Multimodal Imaging Features
Retin Cases Brief Rep. 2026 Sep 1;20(5):632-641. doi: 10.1097/ICB.0000000000001768.
MacTel2 intraretinal fibrosis Multimodal imaging features: Found in 2% of eyes; Seen in late stage; Likely from Müller, activated glial cells, and RPE cells with vascular remodeling — Retrospective, 7 eyes
Functional and Anatomic Outcomes in Eyes With Primary Epiretinal Membranes After Surgical Removal: 5-Year Results of the Pan American Collaborative Retina Study Group
J Vitreoretin Dis. 2026 Apr 21:24741264261438472. doi: 10.1177/24741264261438472.
PPV primary ERM At 5-years VA improved regardless of ERM stage. Pre- and postop ectopic inner foveal layer thickness did not correlate with postop VA — Retrospective, 65 eyes
Impact of postoperative positioning on surgical and visual outcomes after pars plana vitrectomy for rhegmatogenous retinal detachment: a systematic review and meta-analysis
Int J Retina Vitreous. 2026 Jun 25;12(1):122. doi: 10.1186/s40942-026-00890-7.
PPV RRD Evidence doesn’t support superiority of prone positioning, which should be determined by break location and other patient-specific factors — Systematic review and Meta-analysis
Pediatric Radiation Retinopathy: Impact of Early Diagnosis and Targeted Treatment
J Vitreoretin Dis. 2026 Apr 15:24741264261438443. doi: 10.1177/24741264261438443.
Pediatric radiation retinopathy: Early Dx with Avastin improved VA and anatomy with stable retinoblastoma — Retrospective, 19 patients
Incidence, Prevalence, and Risk of Retinal Detachment and Tears Up to 10 Years After Phacoemulsification in a Large US Cohort
J Vitreoretin Dis. 2026 Apr 26:24741264261432182. doi: 10.1177/24741264261432182.
Post-phaco RRD: Up to 10 years post-op sustained increased RD risk. Risk 0.27% at 1-month and 1.41% at 10-years — Retrospective, TriNetX database
Oral therapeutic interventions for central serous chorioretinopathy: A systematic review
Graefes Arch Clin Exp Ophthalmol. 2026 Sep;264(9):2589-2599. doi: 10.1007/s00417-026-07253-w.
ICSC oral therapeutics: Mineralocorticoid receptor antagonists may reduce SRF, although VA benefits are uncertain. Propranolol limited evidence for benefits — Systematic Review
Comparison of prognostic outcomes in vitrectomy for myopic foveoschisis with foveal detachment: air tamponade versus no-air tamponade
Int J Retina Vitreous. 2026 Jun 27;12(1):127. doi: 10.1186/s40942-026-00884-5.
PPV for myopic foveoschisis with foveal detachment: Air (vs no air) tamponade increased early anatomic recovery, but similar long-term anatomic and VA outcomes — Retrospective, 47 eyes
Endophthalmitis Associated with Intravitreal Injections: Rates, Culture Results, and Visual Acuity Outcomes
Retina. 2026 Sep 1;46(9):1486-1491. doi: 10.1097/IAE.0000000000004855.
Post-intravitreal injection endophthalmitis incidence 0.0072% at BPEI — Retrospective, 2021-2025
Comparison Between Thin and Thick Choroid Eyes in Central Serous Chorioretinopathy
Retina. 2026 Sep 1;46(9):1570-1577. doi: 10.1097/IAE.0000000000004875.
ICSC: Thin-choroid (250 microns or less) distinct phenotype with older age and females; CNV more frequent in this group — Retrospective, 355 eyes, MICRoN Study Group
Extraocular silicone oil deposition: a clinicopathologic case series
Graefes Arch Clin Exp Ophthalmol. 2026 Sep;264(9):2871-2876. doi: 10.1007/s00417-026-07229-w.
Extraocular silicone oil deposition in ocular adnexa (conjunctiva, eyelid, orbit) — Retrospective, 25 clinicopathologic specimens
Intravitreous Methotrexate and Rituximab for Bilateral Diffuse Uveal Melanocytic Proliferation
Retin Cases Brief Rep. 2026 Sep 1;20(5):607-611. doi: 10.1097/ICB.0000000000001943.
BDUMP: Intravitreal methotrexate and rituximab Ongoing injections well-tolerated, improved foveal thickness, and fluid — Retrospective, 5 eyes (3 patients)
Intravitreal Povidone-Iodine Monotherapy as an Alternative Treatment for Exogenous Endophthalmitis in Patients With Antibiotic Allergies
J Vitreoretin Dis. 2026 Apr 13:24741264261432184. doi: 10.1177/24741264261432184.
Exogenous endophthalmitis treatment: Intravitreal 0.1cc 1.25% povidone-iodine effective in patients with antibiotic allergies — Retrospective, 7 eyes
Immune Checkpoint Inhibitor-Associated Uveitis: Insights From Comparative Analyses Across Malignancies and Drug Classes
Am J Ophthalmol. 2026 Sep:289:282-291. doi: 10.1016/j.ajo.2026.05.046.
Immune checkpoint inhibitor-associated uveitis: Melanoma intrinsically higher risk; Renal cell CA largely ipilimumab-nivolumab driven — Retrospective, TriNetX database
Association Between the Social Deprivation Index and Neovascular Age-Related Macular Degeneration Outcomes
J Vitreoretin Dis. 2026 Jun 19:24741264261442916. doi: 10.1177/24741264261442916.
nAMD worse social deprivation index associated with worse VA outcomes despite similar baseline VA and treatment exposure — Retrospective, cohort, 643 patients
Perivascular Multifocal Choroiditis with Panuveitis: Clinical and Multimodal Imaging Features
Retina. 2026 Sep 1;46(9):1492-1504. doi: 10.1097/IAE.0000000000004880.
Perivascular multifocal choroiditis with panuveitis: New MFC spectrum phenotype, distinct from vasculitis and inflammatory chorioretinal mimickers — Retrospective, 8 patients
Survival Rates After Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy
J Vitreoretin Dis. 2026 Apr 14:24741264261432178. doi: 10.1177/24741264261432178.
Post-PDR PPV Long-term patient survival rates stable over the prior 2 decades, despite advances in diabetic care. Survival rates 89% 3-year, 81% 5-year, 81% 10-year — Retrospective, TriNetX database
Ciliary Neurotrophic Factor Therapy for Macular Telangiectasia Type 2: A Systematic Review
Retina. 2026 Sep 1;46(9):1505-1512. doi: 10.1097/IAE.0000000000004852.
MacTel2 ciliary neurotrophic factor therapy seems to slow retinal degeneration and preserve visual function. Further trials are needed to assess long-term efficacy — Systematic Review
Dexamethasone Implant and Aflibercept Combination Therapy Versus Aflibercept Monotherapy for Diabetic Macular Edema: A Prospective, Comparative Trial (COED Trial)
Retina. 2026 Sep 1;46(9):1520-1531. doi: 10.1097/IAE.0000000000004858.
DME Eylea+Ozurdex vs Eylea monotherapy: Combined Rx similar VA and anatomic outcomes with quicker DME resolution, BUT higher risk for cataract and increased IOP (COED Trial) — Prospective, RCT, 50 patients
Effects of Time from Diagnosis to Treatment and Baseline Vision on Retinal Vein Occlusion Outcomes in Aflibercept 2 mg Phase III Trials
Ophthalmol Retina. 2026 Sep;10(9):966-974. doi: 10.1016/j.oret.2026.04.027.
COPERNICUS/GALILEO/VIBRANT post hoc Eylea for RVO ME: Longer time to starting treatment was followed by less VA improvement; worse baseline VA was associated with greater VA improvement, but worse final VA.
Morphologic Staging of Photoreceptor Damage as a Predictor of Visual Recovery After PDT in Chronic Central Serous Chorioretinopathy
Am J Ophthalmol. 2026 Sep:289:97-109. doi: 10.1016/j.ajo.2026.05.020.
Chronic ICSC PDT Morphologic OCT staging of photoreceptor damage as a predictor of VA recovery — Retrospective, 139 eyes
Charles Bonnet syndrome in patients referred for cataract surgery
Graefes Arch Clin Exp Ophthalmol. 2026 Sep;264(9):2783-2793. doi: 10.1007/s00417-026-07241-0.
Charles Bonnet syndrome present in 5% of patients referred for cataract surgery, most without retinal pathology and associated with lower VA in the better-seeing eye — Prospective, 391 patients
Ocular Symptoms Lead to Shortest Diagnostic Delay in Biopsy-Proven Giant Cell Arteritis: A Nationwide Veterans Health Study
Am J Ophthalmol. 2026 Aug:288:315-324. doi: 10.1016/j.ajo.2026.04.013.
Biopsy-proven GCA: Visual symptoms prompt more rapid Dx and Tx vs nonspecific symptoms — Retrospective, 300 patients
